This is only good news. $15 million awarded for 7 separate cannabinoid/psychedelic trials (two with MDMA, one with DMT, one with cannabidiol, and three with psilocybin) - targeting a diverse range of mental health and neurological conditions.
In all honesty I don't know if EMD are involved in any of these trials in particular, but this is a huge leap forward for Australian psychedelic research and the industry in general.
EMD Price at posting:
38.0¢ Sentiment: Buy Disclosure: Held
